Orderpad | Uranium Stocks Down 20%+! Nuclear Energy Boom & 2 ASX Stock Picks (URNM & SLX)

Uranium stocks have fallen more than 20%, yet the global nuclear energy outlook continues to strengthen. Is this a buying opportunity, or is the market signalling something investors are missing?

In this episode of Talk Money To Me, Felicity explores the nuclear energy renaissance, the global uranium supply deficit, and why nuclear power could become one of the most important investment themes of the next decade.

With AI data centres driving unprecedented electricity demand, governments prioritising energy security, and major technology companies including Amazon, Google and Microsoft investing in nuclear power, the industry is attracting significant attention.

But there's a problem: uranium supply isn't keeping pace with projected demand.

The world's nuclear reactors currently require approximately 190 million pounds of uranium annually, compared with primary mine production of around 150 million pounds. By 2040, uranium requirements could approach 390 million pounds annually.

So why are uranium equities falling?

Felicity unpacks the disconnect between improving nuclear fundamentals and weakening share prices, including geopolitical uncertainty, uranium mining challenges, utility contracting delays and the impact of the AI trade.

She also examines how the Strait of Hormuz oil shock is reinforcing the importance of energy independence and why the US remains heavily reliant on imported uranium.

☢️ THIS WEEK'S ORDERPAD PICKS

1. Betashares Global Uranium ETF (ASX: URNM) Diversified exposure to global uranium producers, developers and physical uranium investments. Felicity discusses the recent sell-off, the ETF's index changes and why the long-term uranium supply-demand imbalance remains compelling.

2. Silex Systems (ASX: SLX) A long-standing Orderpad investment idea with exposure to advanced uranium enrichment technology and the US nuclear fuel supply chain. Felicity revisits Silex's partnership with Cameco, the Paducah project, commercialisation milestones and its long-term growth potential. At the indicative A$3.65 share price discussed, Shaw and Partners' A$12.80 price target implies approximately 251% theoretical upside, while the indicated A$10.20 analyst consensus implies approximately 179% upside. These targets are forecasts, not guaranteed returns.

ALSO COVERED

Constellation Energy (NASDAQ: CEG) and its nuclear power agreements with major technology companies. Eagle Nuclear Energy (NASDAQ: NUCL), US uranium resources and small modular reactor technology. Why nuclear power is about more than AI: energy security, electrification and reliable low-carbon electricity. The potential for a long-term uranium supercycle and the risks investors need to understand.

Is the uranium sell-off creating an opportunity? Listen now as Felicity breaks down the investment case and reveals her two ASX Orderpad picks. Subscribe to Talk Money To Me for market insights, investment research and stock discussions.

DISCLAIMER This podcast is for general information purposes only and does not constitute personal financial advice. It does not consider your individual objectives, financial situation or needs. References to securities, ETFs, price targets and investment strategies are not personal recommendations to buy, sell or hold investments. All investments involve risk, including possible loss of capital. Uranium equities and emerging nuclear technologies can be particularly volatile. Analyst forecasts and price targets are subject to change and may not be achieved. Past performance is not a reliable indicator of future performance. Information and prices are based on sources available at the time of recording and may change. Consider relevant disclosure documents and seek professional financial advice before making investment decisions.

#TalkMoneyToMe #Orderpad #UraniumStocks #NuclearEnergy #ASX #SLX #URNM #SilexSystems #UraniumETF #Investing #StockMarket #AIInfrastructure Hosted on Acast. See acast.com/privacy for more informatio